Health
GenEros to Present Promising Results of GEC255 Phase I Clinical Trial for Advanced NSCLC Patients with KRAS G12C Mutation
HANGZHOU, China, June 1, 2023 /PRNewswire/ -- GenEros Biopharma Ltd. ("GenEros" or "the Company"), a biopharmaceutical company dedicated to discovering, developing, and commercializing novel medicines for diseases with unmet medical needs, will unveil the preliminary data from the phase I clinica...
2023-06-01 22:15
2433
Impact Therapeutics Entered into Global Partnership with Eikon Therapeutics to Develop and Commercialize PARP1 Selective Inhibitors
SHANGHAI and HAYWARD, Calif., June 1, 2023 /PRNewswire/ -- IMPACT Therapeutics ("Impact"), a biopharmaceutical company focusing on the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality, and Eikon Therapeutics ("Eikon"), a biotechnology company that is adv...
2023-06-01 20:30
2235
Aravax doses first patient in Phase 2 peanut allergy clinical trials
MELBOURNE, Australia, June 1, 2023 /PRNewswire/ -- The first patient has been dosed in a Phase 2 study (AVX-201) being run by biotechnology company Aravax, which is developing the novel therapy PVX108 for the safe and convenient treatment of peanut allergy. The study is being conducted under a U....
2023-06-01 20:00
1846
BIORCHESTRA Invited to Present Update on Central Nervous System Lead Program (BMD-001) and IV-Formulated siRNA Data at BIO2023 International Conference
* Presentation:"Successfully Achieving Intravenous (IV)-formulated RNA Delivery to the Brain, Evidence of Efficacy" scheduled for June 08, 2023, 12:00 p.m. ET, Room 104A * Pioneering IV-formulated inert drug delivery platform targeting neurodegenerative diseases * Lead program (BMD-001) adv...
2023-06-01 20:00
2175
Seegene Obtains IVDR Certification for 30 Diagnostic Assays
* Seegene certifies diagnostic assays for digestive, respiratory, women's diseases, and human papillomavirus to meet IVDR requirements * New regulation sets improved standards to ensure higher level of quality, safety, and reliability SEOUL, South Korea, June 1, 2023 /PRNewswire/ -- Seegene I...
2023-06-01 19:00
2037
Kombucha Continues to Trend! TCI Received the Golden Award at the Geneva International Exhibition of Inventions
TAIPEI, June 1, 2023 /PRNewswire/ -- Beauty and anti-aging have become a global trend. InMay 2023, TCI (tt 8436) won gold, silver, and a bronze award at the Geneva International Exhibition of Inventions for its three exclusive ingredient formulas: Probio-Kombu black tea, Mango Unripe Fruit Extrac...
2023-06-01 18:06
2116
Xinhua Silk Road: Activity to promote TCM cultural exchanges and cooperation between China and Luxembourg completes success
BEIJING, June 1, 2023 /PRNewswire/ -- An activity to promote traditional
Chinese medicine (TCM) cultural exchanges and cooperation betweenChina and
Luxembourg held recently at the Luxembourg Embassy in China achieved a complete
success.
2023-06-01 17:37
1988
Xinhua Silk Road: Global co-op highlighted in tour of Chinese herbs firm to Indonesian embassy in China
BEIJING, June 1, 2023 /PRNewswire/ -- A tour to the Indonesian embassy in China
by representatives from Zhejiang Longevity Valley Botanical Co., Ltd. cast a
spot light on the rising importance of cooperation and communication in the era
of globalization.
2023-06-01 17:35
2278
WuXi Biologics to Increase Manufacturing Capacity in Germany
- In response to global clients' increasing demand for contract manufacturing services, WuXi Biologics is expanding its capacity for drug substance and drug product inGermany - The investment promotes the creation of additional high-skilled jobs - As part of WuXi Biologics' global manufacturi...
2023-06-01 16:49
3409
Mediso installs 100% cryogen-free 7T MRI at the University of Milano-Bicocca, Italy
BUDAPEST, Hungary, June 1, 2023 /PRNewswire/ -- Mediso
2023-06-01 16:00
2064
CBC GROUP RELEASES 2022 ESG REPORT
Guided by the firm's commitment to drive positive and meaningful impact while delivering better healthcare for all SINGAPORE, May 31, 2023 /PRNewswire/ -- CBC Group ("CBC"), Asia's largest healthcare-dedicated investment firm, today published its Environmental, Social and Governance ("ESG")...
2023-06-01 10:00
2306
Xinhua Silk Road: Chinese Lingzhi brand Longevity Valley promotes inheritance of a century-old national treasure to Brunei foreign envoys
BEIJING, May 31, 2023 /PRNewswire/ -- A delegation of the renowned Chinese Lingzhi brand, Zhejiang Longevity Valley Botanical Co., Ltd, recently visited the Embassy ofBrunei Darussalam in China to showcase Chinese traditional culture and wisdom of health philosophy embedded in the brand toBrunei....
2023-06-01 09:47
2195
Amplo Biotechnology Secures Fast Track STTR Funding for AMP-201, a Promising Gene Therapy Targeting Collagen Q Deficiency
SAN DIEGO, May 29, 2023 /PRNewswire/ -- Amplo Biotechnology, a leading US-based biotech company dedicated to developing innovative AAV-based gene therapies for neuromuscular junction disorders announced the award of a Fast Track Phase I/II STTR grant from theNIH-NINDS. This highly competitive gra...
2023-06-01 04:24
3665
Actinogen to present progress on Cognitive Impairment in Depression and Alzheimer's Disease Phase 2 trials at the BIO International Convention
Xanamem® is an oral, brain-penetrant tissue cortisol synthesis inhibitor that has shown promising safety and clinical activity in three placebo-controlled trials and has the potential to treat a variety of neurodegenerative and neuropsychiatric diseases SYDNEY, May 31, 2023 /PRNewswire/ -- Actin...
2023-05-31 20:58
2192
QBIOTICS TO PRESENT AT SACHS 9TH ANNUAL IMMUNO-ONCOLOGY INNOVATION FORUM AND THE BIO INTERNATIONAL CONVENTION
BRISBANE, Australia, May 31, 2023 /PRNewswire/ -- QBiotics Group Limited ( QBiotics), a clinical stage life sciences company developing novel small molecule anticancer and wound healing pharmaceuticals is pleased to announce thatRichard Godfrey will present to potential partners and investors at t...
2023-05-31 19:00
2678
Asieris' progress in MIBC receives renewed attention with its inclusion in ASCO 2023
SHANGHAI, May 31, 2023 /PRNewswire/ -- Asieris Pharmaceuticals (688176)， a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced the phase I clinical data of ANTICIPATE ...
2023-05-31 16:00
1769
Yuhan Corporation and J INTS BIO inked a licensing agreement for a New Drug Candidate targeting HER2 NSCLC
SEOUL, South Korea, May 31, 2023 /PRNewswire/ -- Yuhan Corporation (CEO, Wook-Je Cho) announced on the 30th of May that it has signed an in-license agreement with J INTS BIO (CEO,Anna Jo) for a Tyrosine Kinase Inhibitor (TKI) targeting HER2, 'JIN-A04'. The total contract size is325 million dollar...
2023-05-31 13:02
1579
Waterdrop Inc. Announces Earnings Date Change: First Quarter 2023 Earnings Release Scheduled June 2, 2023
BEIJING, May 30, 2023 /PRNewswire/ -- Waterdrop Inc. (NYSE: WDH
2023-05-31 11:19
3293
Ascentage Pharma's Novel Drug Olverembatinib Recommended for a Breakthrough Therapy Designation in China for the Treatment of SDH-Deficient GIST, the Second BTD for the Drug
SUZHOU, China and ROCKVILLE, Md., May 30, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announcedtoday that the Center for Drug Evaluation (CDE) of China Na...
2023-05-31 10:20
1888
Boryung Partners with Axiom Space and Aurelia Institute to Launch the "2023 Humans In Space" Program
* "Humans In Space" program co-hosted by Boryung, Axiom Space and Aurelia Institute to explore three interdisciplinary pillars of healthcare, lifestyle, and platform in hopes of shaping the future of interplanetary civilization. * Boryung aims to expand the space healthcare ecosystem, establis...
2023-05-30 21:00
2188
Week's Top Stories
Most Reposted
Agoda and TPB Philippines join hands to bring the world to the Philippines' shores
[Picked up by 350 media titles]
2024-09-18 11:30
FETC International's MD Dr. Y.C. Chang Honored with the "Master Entrepreneur Award" at APEA 2024
[Picked up by 315 media titles]
2024-09-16 11:50
Mox Capital Announces Strategic Support for Rapid-Scaling Startups Across Vietnam and Southeast Asia
[Picked up by 284 media titles]
2024-09-14 17:37
Illumina and LGC Biosearch Technologies join forces to drive genomic innovation in agriculture
[Picked up by 283 media titles]
2024-09-19 14:00
Watsons-Marlow unveils Qdos™ H-FLO and WMArchitectTM :Innovating fluid solutions for the chemical and biopharmaceutical industries respectively
[Picked up by 274 media titles]
2024-09-19 08:00
Most Read
Mox Capital Announces Strategic Support for Rapid-Scaling Startups Across Vietnam and Southeast Asia
2024-09-14 17:37
9772
Maiji Mountain Grottoes: Carved in stone, evolving in time
2024-09-14 13:23
8197
FETC International's MD Dr. Y.C. Chang Honored with the "Master Entrepreneur Award" at APEA 2024
2024-09-16 11:50
8120
Vision China: US, China urged to find right path in ties
2024-09-14 01:10
7681
Agoda and TPB Philippines join hands to bring the world to the Philippines' shores
2024-09-18 11:30
6228